StemgenicsR

Nanotherapeutics IN VIVO Reprogramming

Contact Us

Mailing Address:

Andranik Andrew Aprikyan, Ph.D.
Chief Executive Officer
Stemgenics, Inc.
454 N 34th Street, Suite 100
Seattle, WA 98103